Pharmacokinetics Distribution of Raltegravir by PET/MR
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California
- Dates
- study startedcompletion around
- Principal Investigator
- by Timothy J Henrich, MD
Description
Summary
Official Title
Keywords
Eligibility
Location
Lead Scientist at UCSF
- Timothy J Henrich, MD
My laboratory/research group specializes in immunmodulatory, cytoreductive chemotherapeutic and stem cell transplantation approaches to HIV-1 cure. We are also involved in the design and implementation of novel nano/microtechnologies and PET-based imaging approaches to characterize viral reservoirs.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT03174977
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 10 study participants
- Last Updated